- Home
- ZLAB vs BIPC Comparison
ZLAB vs BIPC Comparison
Compare ZLAB & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- BIPC
- Stock Information
- Founded
- ZLAB 2013
- BIPC 2019
- Country
- ZLAB China
- BIPC United States
- Employees
- ZLAB N/A
- BIPC N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- BIPC Marine Transportation
- Sector
- ZLAB Health Care
- BIPC Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- BIPC Nasdaq
- Market Cap
- ZLAB 4.3B
- BIPC 4.7B
- IPO Year
- ZLAB 2017
- BIPC N/A
- Fundamental
- Price
- ZLAB $34.96
- BIPC $39.74
- Analyst Decision
- ZLAB Buy
- BIPC
- Analyst Count
- ZLAB 5
- BIPC 0
- Target Price
- ZLAB $54.28
- BIPC N/A
- AVG Volume (30 Days)
- ZLAB 860.8K
- BIPC 550.6K
- Earning Date
- ZLAB 08-07-2025
- BIPC 01-01-0001
- Dividend Yield
- ZLAB N/A
- BIPC 4.33%
- EPS Growth
- ZLAB N/A
- BIPC N/A
- EPS
- ZLAB N/A
- BIPC N/A
- Revenue
- ZLAB $427,799,000.00
- BIPC $3,651,000,000.00
- Revenue This Year
- ZLAB $45.16
- BIPC $65.08
- Revenue Next Year
- ZLAB $56.81
- BIPC $6.15
- P/E Ratio
- ZLAB N/A
- BIPC N/A
- Revenue Growth
- ZLAB 32.56
- BIPC 11.38
- 52 Week Low
- ZLAB $16.01
- BIPC $32.08
- 52 Week High
- ZLAB $44.34
- BIPC $43.41
- Technical
- Relative Strength Index (RSI)
- ZLAB 45.24
- BIPC 42.58
- Support Level
- ZLAB $33.17
- BIPC $38.11
- Resistance Level
- ZLAB $39.64
- BIPC $42.02
- Average True Range (ATR)
- ZLAB 1.19
- BIPC 0.78
- MACD
- ZLAB -0.31
- BIPC -0.18
- Stochastic Oscillator
- ZLAB 22.29
- BIPC 39.85
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.